[{"figure_path": "40pE5pFhWl/tables/tables_6_1.jpg", "caption": "Table 1: Stability and validity results on QM9 and GEOM-DRUGS obtained over 10000 samples, with mean/standard deviation across 3 sampling runs. END compares favorably to the baseline across all metrics on both datasets, while offering competitive performance for reduced number of sampling steps. It reaches a performance level similar to that of current SOTA methods. \u2021 denotes results obtained by our own experiments.", "description": "This table presents the stability and validity results of the END model and various baselines on QM9 and GEOM-DRUGS datasets. The metrics used are: stability (A[%], M[%], V[%]), validity/uniqueness (VxU[%]), and validity/connectivity (VxC[%]). The END model demonstrates competitive performance compared to the state-of-the-art models, particularly with a reduced number of sampling steps. The table highlights the consistent improvement of END across different evaluation metrics and datasets.", "section": "4.1 Unconditional Generation"}, {"figure_path": "40pE5pFhWl/tables/tables_7_1.jpg", "caption": "Table 2: Additional results on QM9 and GEOM-DRUGS obtained over 10000 samples, with mean/standard deviation across 3 sampling runs. END matches better the training distributions, and generates less strained structures than baselines. \u2021 denotes results obtained by our own experiments.", "description": "This table presents additional quantitative results on the QM9 and GEOM-Drugs datasets to complement Table 1.  It shows the total variation (TV), atom types distribution (A and B), and strain energy (\u0394E) for different models and numbers of integration steps.  Lower TV values indicate better agreement with the training data distribution, and lower strain energy (\u0394E) signifies that the model generates less strained structures.  The results demonstrate that END consistently outperforms baselines in terms of matching the training distribution and producing less strained molecules. ", "section": "4.1 Unconditional Generation"}, {"figure_path": "40pE5pFhWl/tables/tables_8_1.jpg", "caption": "Table 3: On composition-conditioned generation, CEND offers nearly perfect composition controllability. Matching refers to the % of samples featuring the prompted composition.", "description": "This table presents the results of composition-conditioned molecule generation experiments.  The experiment aimed to generate molecules with a specific composition (defined by the number of each atom type). The table compares the performance of CEND (the proposed model) against CEDM* (a baseline model) across different numbers of sampling steps.  The \"Matching [%]\" column shows the percentage of generated molecules that successfully matched the target composition.  The results demonstrate CEND's superior ability to control the generated molecule's composition.", "section": "4.2 Conditional Generation"}, {"figure_path": "40pE5pFhWl/tables/tables_8_2.jpg", "caption": "Table 4: On substructure-conditioned generation, CEND shows competitive performance, surpassing EEGSDE that uses an additional property predictor. Results are borrowed from Bao et al. (2023).", "description": "This table presents the results of substructure-conditioned molecule generation experiments.  It compares the performance of the proposed CEND model against the EEGSDE baseline model in terms of Tanimoto similarity scores. Higher Tanimoto similarity indicates a better match between the generated molecules' substructures and the target substructures specified as conditions. The results show that CEND significantly outperforms EEGSDE, demonstrating its superior ability to control the generation process based on provided substructure information.", "section": "4.2 Conditional Generation"}, {"figure_path": "40pE5pFhWl/tables/tables_14_1.jpg", "caption": "Table 5: Compared models.", "description": "This table compares different diffusion models used in the paper, focusing on their forward transformation function, F.  It shows how each model defines F, highlighting the differences in their approaches.  In particular, it shows the equations used to calculate the transformation and the parameters involved for each model. The models include EDM, GEOLDM, EDM* + \u03a5\u03c6, END (\u03bc\u03c6 only), and END.  The 'Comment' column provides additional context and explanations for each model's approach.", "section": "A.1 Compared models"}, {"figure_path": "40pE5pFhWl/tables/tables_14_2.jpg", "caption": "Table 1: Stability and validity results on QM9 and GEOM-DRUGS obtained over 10000 samples, with mean/standard deviation across 3 sampling runs. END compares favorably to the baseline across all metrics on both datasets, while offering competitive performance for reduced number of sampling steps. It reaches a performance level similar to that of current SOTA methods. \u2021 denotes results obtained by our own experiments.", "description": "This table presents the results of stability and validity experiments on two datasets (QM9 and GEOM-Drugs) for molecule generation.  It compares the performance of the proposed END model against several baselines, using different numbers of sampling steps. The metrics evaluated include stability (A[%], M[%]), validity (V[%]), and uniqueness (V\u00d7U[%]). The table highlights END's competitive performance and its ability to achieve comparable results with fewer steps.", "section": "4.1 Unconditional Generation"}, {"figure_path": "40pE5pFhWl/tables/tables_15_1.jpg", "caption": "Table 7: Additional results of the ablation study with metrics from HIERDIFF (Qiang et al., 2023) and MMD (Gretton et al., 2012; Daigavane et al., 2024) on QM9. The two variants of END shows better, or on par, agreement with the true data distribution compared to the baselines.", "description": "This table presents additional evaluation metrics for the ablation study on the QM9 dataset.  It compares the performance of different model variations (END, EDM*, EDM*+\u03a5\u03c6, END (\u00b5\u03c6 only)) using metrics from HIERDIFF and MMD. The focus is on how well the models capture the true data distribution.  The results show that END variants generally perform better or on par with the baselines.", "section": "4.1 Unconditional Generation"}, {"figure_path": "40pE5pFhWl/tables/tables_16_1.jpg", "caption": "Table 3: On composition-conditioned generation, CEND offers nearly perfect composition controllability. Matching refers to the % of samples featuring the prompted composition.", "description": "This table presents the results of composition-conditioned generation experiments.  It compares the performance of three models (CEDM*, CEND (\u00b5\u03c6 only), and CEND) across different numbers of sampling steps (50, 100, 250, 500, 1000). The key metric is \"Matching [%]\", which represents the percentage of generated samples that perfectly match the target composition.  Higher percentages indicate better controllability of the generation process.", "section": "4.2 Conditional Generation"}, {"figure_path": "40pE5pFhWl/tables/tables_16_2.jpg", "caption": "Table 1: Stability and validity results on QM9 and GEOM-DRUGS obtained over 10000 samples, with mean/standard deviation across 3 sampling runs. END compares favorably to the baseline across all metrics on both datasets, while offering competitive performance for reduced number of sampling steps. It reaches a performance level similar to that of current SOTA methods. \u2021 denotes results obtained by our own experiments.", "description": "This table presents the stability and validity results of the END model and several baselines on the QM9 and GEOM-DRUGS datasets.  The metrics used to evaluate the models include stability, validity, uniqueness, and various other metrics for drug-related properties. The table shows that END outperforms or is comparable to existing state-of-the-art methods across different evaluation metrics and sampling steps, highlighting its robustness and efficiency.", "section": "4.1 Unconditional Generation"}, {"figure_path": "40pE5pFhWl/tables/tables_17_1.jpg", "caption": "Table 1: Stability and validity results on QM9 and GEOM-DRUGS obtained over 10000 samples, with mean/standard deviation across 3 sampling runs. END compares favorably to the baseline across all metrics on both datasets, while offering competitive performance for reduced number of sampling steps. It reaches a performance level similar to that of current SOTA methods. \u2021 denotes results obtained by our own experiments.", "description": "This table compares the performance of the END model against several baselines on two datasets, QM9 and GEOM-DRUGS, using various metrics related to stability, validity, and uniqueness of generated molecules.  The results show that END performs competitively with or surpasses the state-of-the-art methods, especially with fewer sampling steps.", "section": "4.1 Unconditional Generation"}, {"figure_path": "40pE5pFhWl/tables/tables_25_1.jpg", "caption": "Table 1: Stability and validity results on QM9 and GEOM-DRUGS obtained over 10000 samples, with mean/standard deviation across 3 sampling runs. END compares favorably to the baseline across all metrics on both datasets, while offering competitive performance for reduced number of sampling steps. It reaches a performance level similar to that of current SOTA methods. \u2021 denotes results obtained by our own experiments.", "description": "This table presents the stability and validity results of the END model and several baselines on the QM9 and GEOM-DRUGS datasets.  The metrics used include stability, validity, uniqueness (QM9), connectivity (GEOM-DRUGS), and combinations thereof.  The results show END performing comparably to or better than state-of-the-art methods, especially with fewer sampling steps, indicating efficiency gains.", "section": "4.1 Unconditional Generation"}]